ArticleMethods in molecular biology (Clifton, N.J.)2025
Combination of Antibody Arrays to Characterize the Effect of Neuropathological Stimulus in Human Olfactory Neuroepithelial Cells.
Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
It has been established that smell impairment is a common early feature of neurodegenerative diseases (NDs), being most prevalent in Alzheimer's disease patients. As well as in other brain regions, the deposition of pathological substrates such as amyloid peptides (Aβ) or the hyperphosphorylated form of tau has been suggested as a potential origin of olfactory deficits. Nevertheless, other trends of thought are now suggesting the detriment in the soluble forms of these proteins as potentially responsible of the neurodegenerative process. Either way, the molecular mechanisms triggered by the presence and aggregation of these pathological substrates are not fully understood. In this chapter, we describe a workflow combining the use of neuropathological substrates depicting a neurodegenerative environment in an olfactory-related context with the employment of protein arrays targeting both extracellular and intracellular proteins aiming to characterize the molecular mechanisms underlying the established role of neuropathological hallmarks.
Indexed as
Identifiers
40601155What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.